117 related articles for article (PubMed ID: 21055618)
1. Multivalent cyclic RGD ligands: influence of linker lengths on receptor binding.
Kubas H; Schäfer M; Bauder-Wüst U; Eder M; Oltmanns D; Haberkorn U; Mier W; Eisenhut M
Nucl Med Biol; 2010 Nov; 37(8):885-91. PubMed ID: 21055618
[TBL] [Abstract][Full Text] [Related]
2. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
3. Functionalized cyclic RGD peptidomimetics: conjugable ligands for αvβ3 receptor imaging.
Arosio D; Manzoni L; Araldi EM; Caprini A; Monferini E; Scolastico C
Bioconjug Chem; 2009 Aug; 20(8):1611-7. PubMed ID: 21141806
[TBL] [Abstract][Full Text] [Related]
4. Cyclic RGD-polyethylene glycol-polyethylenimine for intracranial glioblastoma-targeted gene delivery.
Zhan C; Meng Q; Li Q; Feng L; Zhu J; Lu W
Chem Asian J; 2012 Jan; 7(1):91-6. PubMed ID: 22072592
[TBL] [Abstract][Full Text] [Related]
5. Multimerization of cRGD peptides by click chemistry: synthetic strategies, chemical limitations, and influence on biological properties.
Wängler C; Maschauer S; Prante O; Schäfer M; Schirrmacher R; Bartenstein P; Eisenhut M; Wängler B
Chembiochem; 2010 Oct; 11(15):2168-81. PubMed ID: 20827791
[TBL] [Abstract][Full Text] [Related]
6. RGD modified albumin nanospheres for tumour vasculature targeting.
Dubey PK; Singodia D; Verma RK; Vyas SP
J Pharm Pharmacol; 2011 Jan; 63(1):33-40. PubMed ID: 21155813
[TBL] [Abstract][Full Text] [Related]
7. Specific detection of integrin αvβ3 by light-up bioprobe with aggregation-induced emission characteristics.
Shi H; Liu J; Geng J; Tang BZ; Liu B
J Am Chem Soc; 2012 Jun; 134(23):9569-72. PubMed ID: 22642547
[TBL] [Abstract][Full Text] [Related]
8. Cyclic RGD peptide-conjugated polyplex micelles as a targetable gene delivery system directed to cells possessing alphavbeta3 and alphavbeta5 integrins.
Oba M; Fukushima S; Kanayama N; Aoyagi K; Nishiyama N; Koyama H; Kataoka K
Bioconjug Chem; 2007; 18(5):1415-23. PubMed ID: 17595054
[TBL] [Abstract][Full Text] [Related]
9. Determination of the binding epitope of RGD-peptidomimetics to αvβ3 and α(IIb)β3 integrin-rich intact cells by NMR and computational studies.
Guzzetti I; Civera M; Vasile F; Araldi EM; Belvisi L; Gennari C; Potenza D; Fanelli R; Piarulli U
Org Biomol Chem; 2013 Jun; 11(23):3886-93. PubMed ID: 23657523
[TBL] [Abstract][Full Text] [Related]
10. Cyclic RGD peptides interfere with binding of the Helicobacter pylori protein CagL to integrins αVβ3 and α5β1.
Conradi J; Huber S; Gaus K; Mertink F; Royo Gracia S; Strijowski U; Backert S; Sewald N
Amino Acids; 2012 Jul; 43(1):219-32. PubMed ID: 21915696
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biochemical evaluation of a cyclic RGD oxorhenium complex as new ligand of alphaVbeta3 integrin.
Aufort M; Gonera M; Chaignon N; Le Clainche L; Dugave C
Eur J Med Chem; 2009 Sep; 44(9):3394-401. PubMed ID: 19303174
[TBL] [Abstract][Full Text] [Related]
12. Anti-angiogenesis activities of novel peptide complexes: mitochondria-disruptive 9mer peptides conjugated with the integrin alpha V beta 3-homing cyclic RGD motif.
Iwasaki T; Yamakawa M; Asaoka A; Kawano T; Ishibashi J
Biosci Biotechnol Biochem; 2012; 76(11):2044-8. PubMed ID: 23132564
[TBL] [Abstract][Full Text] [Related]
13. Tumor targeting and imaging using cyclic RGD-PEGylated gold nanoparticle probes with directly conjugated iodine-125.
Kim YH; Jeon J; Hong SH; Rhim WK; Lee YS; Youn H; Chung JK; Lee MC; Lee DS; Kang KW; Nam JM
Small; 2011 Jul; 7(14):2052-60. PubMed ID: 21688390
[TBL] [Abstract][Full Text] [Related]
14. Cyclic RGD β-lactam peptidomimetics induce differential gene expression in human endothelial cells.
Aizpurua JM; Ganboa JI; Palomo C; Loinaz I; Oyarbide J; Fernandez X; Balentová E; Fratila RM; Jiménez A; Miranda JI; Laso A; Avila S; Castrillo JL
Chembiochem; 2011 Feb; 12(3):401-5. PubMed ID: 21290542
[No Abstract] [Full Text] [Related]
15. Impact of polyplex micelles installed with cyclic RGD peptide as ligand on gene delivery to vascular lesions.
Kagaya H; Oba M; Miura Y; Koyama H; Ishii T; Shimada T; Takato T; Kataoka K; Miyata T
Gene Ther; 2012 Jan; 19(1):61-9. PubMed ID: 21654819
[TBL] [Abstract][Full Text] [Related]
16. PET Diagnostic Molecules Utilizing Multimeric Cyclic RGD Peptide Analogs for Imaging Integrin α
Liolios C; Sachpekidis C; Kolocouris A; Dimitrakopoulou-Strauss A; Bouziotis P
Molecules; 2021 Mar; 26(6):. PubMed ID: 33810198
[TBL] [Abstract][Full Text] [Related]
17. Cyclic RGD functionalized gold nanoparticles for tumor targeting.
Arosio D; Manzoni L; Araldi EM; Scolastico C
Bioconjug Chem; 2011 Apr; 22(4):664-72. PubMed ID: 21434651
[TBL] [Abstract][Full Text] [Related]
18. Morpholine-based RGD-cyclopentapeptides as alphavbeta3/alphavbeta5 integrin ligands: role of configuration towards receptor binding affinity.
Cini N; Trabocchi A; Menchi G; Bottoncetti A; Raspanti S; Pupi A; Guarna A
Bioorg Med Chem; 2009 Feb; 17(4):1542-9. PubMed ID: 19195898
[TBL] [Abstract][Full Text] [Related]
19. Delivery of the p38 MAPkinase inhibitor SB202190 to angiogenic endothelial cells: development of novel RGD-equipped and PEGylated drug-albumin conjugates using platinum(II)-based drug linker technology.
Temming K; Lacombe M; van der Hoeven P; Prakash J; Gonzalo T; Dijkers EC; Orfi L; Kéri G; Poelstra K; Molema G; Kok RJ
Bioconjug Chem; 2006; 17(5):1246-55. PubMed ID: 16984135
[TBL] [Abstract][Full Text] [Related]
20. Nanoscale integrin ligand patterns determine melanoma cell behavior.
Amschler K; Erpenbeck L; Kruss S; Schön MP
ACS Nano; 2014 Sep; 8(9):9113-25. PubMed ID: 25171587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
